Waters Corp (WAT.N) raised the lower end of its full-year profit forecast on Monday, following stronger-than-expected second-quarter results fueled by rising demand from biotech firms for its laboratory tools used in drug development and research.

In a decisive move, the US House of Representatives has passed legislation to blacklist Chinese biotech companies and their US subsidiaries, despite a last-minute lobbying effort.